chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchy throat trouble breathing coughing for 1.5 hours; Itchy throat trouble breathing coughing for 1.5 hours; Itchy throat trouble breathing coughing for 1.5 hours; Dose Number:3; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received bnt162b2 (BNT162B2) solution for injection dose 3, (Batch/Lot number: unknown) via unspecified route of administration at arm right, on 16Dec2021 12:45 at the age of 42 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Medical tape" (unspecified if ongoing), notes: Medical tape allergy. There were no concomitant medications. Vaccination history included: Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. via unspecified route of administration on an unspecified date, as a dose 1 single for Covid-19 immunization, Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Misplaced/discarded, Location of injection: Arm Left), via unspecified route of administration on 06May2021, when the patient was 41 years old, as a dose 2 single for Covid-19 immunization;. The following information was reported: IMMUNISATION (non-serious) with onset 16Dec2021 12:45, outcome "unknown", described as "Dose Number:3"; THROAT IRRITATION (non-serious), DYSPNOEA (non-serious), COUGH (non-serious) all with onset 16Dec2021 13:00, outcome "recovered" (16Dec2021 14:30) and all described as "Itchy throat trouble breathing coughing for 1.5 hours". Therapeutic measures were not taken as a result of throat irritation, dyspnoea, cough.  Additional information: Reason why batch/lot is Unknown: Not available/provided to reporter at the time of report completion. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Reported Event: Itchy throat trouble breathing coughing for 1.5 hours. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.   The lot number for bnt162b2 was not provided and will be requested during follow up
Pt reports having sore arm from recieving high dose fluzone (LD). Pt claims it resolved in a day.
Arms, chest & back began to ache.  No signs prior, felt fine, standing checking into my Dr.?s office for a regular checkup.  .  I was sent to urgent care & then to hospital .  Many tests were given.  Diagnosis was myocarditis.  My Heart Dr.  issued another text & the  result is apparently it has healed itself.  Very odd considering I have been extremely healthy only bring in a hospital 3 times.  Which were elective.  No heath issues whatsoever.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. On unknown dates, the patient was administered the doses of GARDASIL (lot number not reported) (dose not reported, intramuscular route). Concomitant medications were not reported. The dates of administration of GARDASIL were in accordance to the prescribing information. On an unspecified date after the completion of GARDASIL vaccination, the patient tested positive for HPV through a Pap Smear. The medical assistant was unable to identify the strain of HPV in which the unspecified patient was tested positive for. The patient did not sought medical attention. There was no treatment given for the adverse event. At the time of the report the patient's outcome was unknown. Additional information is not expected.
This spontaneous report was received from a consumer refers to a 87-year-old female patient. Current conditions included colitis, anemia, low blood cells and allergy to penicillin. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported). Concomitant medications included ASACOL, chlordiazepoxided, clidinium bromide and prednisone. The consumer stated that his wife (patient) was administered ZOSTAVAX and on 09-DEC-2012 had extreme weakness, trouble walking, a fever of 103 degrees, her legs and neck hurt and she won't eat. the consumer also indicated that the patient fell. treatment was given for the events, intravenous (IV) at the emergency room. lab tests were performed on 09-DEC-2012. Blood work, X-rays, catscan and urine test were done, results were unknown. The events did not resolve at the time of this report. The patient sought medical attention for the events, Emergency room visit not overnight. Additional information has been requested.
Occipital Neurologica Nerve pain in back of head and spine that has gotten worse over a month.
Case number PHEH2014US024997 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 64 years old female patient. Past medical history and concomitant medications were not reported. The temperature excursion of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on 30 Oct 2014. It was reported that the vaccine administered was at 49 F 12 times over a period of 34 days. There were 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursions. No adverse events were reported following the maladministration.
No adverse effects were reported; HBP called to report that a patient was inadvertently administered an expired dose of PNEUMOVAX 23.  Expired 8/21/2023 and was administered on 9/19/2023. No adverse effects were reported. HCP said HCP also had questions about the potency of the dose.; This spontaneous report has been received from an official manager, regarding a 61-years-old patient of unreported gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 19-SEP-2023, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, at a dose of 0.5 milliliters as prophylaxis (lot number: U032086, which was determined to be valid as syringe formulation, with an expiration date on 29-AUG-2023) (strength, route and anatomical location of administration were not reported) (Expired product administered).  No additional adverse event was reported.
Extreme Irritability/Aggitation, increased impulsivity,  Trouble controlling emotional outbursts, lump under armpit where vaccine was given for 3 days
Large, erythematous, oval rash on thigh over injection site. Appears to be arthus reaction.
Soreness in arm which lasted a few days; Rash at injection site which lasted a few days; Very itchy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm which lasted a few days), VACCINATION SITE RASH (Rash at injection site which lasted a few days) and VACCINATION SITE PRURITUS (Very itchy at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Asthma since an unknown date and COPD since an unknown date. Concomitant products included LEVOTHYROXINE, POTASSIUM and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in arm which lasted a few days), VACCINATION SITE RASH (Rash at injection site which lasted a few days) and VACCINATION SITE PRURITUS (Very itchy at injection site). At the time of the report, PAIN IN EXTREMITY (Soreness in arm which lasted a few days), VACCINATION SITE RASH (Rash at injection site which lasted a few days) and VACCINATION SITE PRURITUS (Very itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    This case was linked to MOD-2021-098781 (Patient Link).
Achy, fatigued, nausea, low temp fever, sore arm, swollen. temp increased at night 100-101, irritable, tearful, tired, swelling increased. Tuesday 2am had hoarse hacking cough, no mucus/ no runny nose. Given fluids. On Wed pt was completely exhausted all day, Thursday called doctor office. Pt had on off headaches. Friday temps down, higher at night, still fatigued and nauseated, swelling down.
pain went down into my left hand and wrist.  The joints are very painful. pain went across my abdoment.
Headache., Chills, Body aches & pain, dizziness, backache,.  All symptoms gone in 24 hours.
ProQuad 10/18/2006. 10/20/2006 thigh warm, red, no drainage. Benadryl PO, local reaction to MMR/V.
Developed swelling & erythema of left thigh size of grapefruit approx 24 hours after injection,Treated with Motrin & Benadryl
Patient tested positive for COVID-19 by PCR on 7/9/21.  Unknown if symptomatic. Received Pfizer vaccines on 1/5/21, 2/5/21.
Subsequent to receiving one dose of varicella virus vaccine live on 9/26/96, the pt experienced varicella illness with 100 lesions lasting 6-7 days with mild fever and mild pruritus on 5/9/99. It was noted that the pt was exposed to varicella prior to the onset of episode.
Woke up at 4:00 am restless.  Could not sleep.  Body aches.  Flu like symptoms by 10:00 am that lasted all day.  Bad headache in the afternoon.  Went to sleep around 9:00 pm.  Felt normal by the next morning.
ON 12/24/20 AT 7PM, DEVELOPED RIGHT SIDED CHEST/ARMPIT/UPPER ARM PAIN. LASTED 7 DAYS PRIOR TO RESOLVING. WAS SEEN IN THE EMERGENCY ROOM.
swelling of lips and under eyes 2 days after second covid vaccine.  Patient with hx of dermal injection
unable to discuss adverse event further w/parent but on 23JAN96 d/t not returning call;was told by mom 23JAN96 that MD had advised that pt not recv hep B #2 or #3 d/t rxn from vax
2nd dose interval exceeded/2nd dose not received; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose interval exceeded/2nd dose not received) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose interval exceeded/2nd dose not received). On 08-Feb-2021, PRODUCT DOSE OMISSION ISSUE (2nd dose interval exceeded/2nd dose not received) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications was not provided.  Concomitant medications was not provided.
R thigh presented with 2x2 area of swelling, redness and pain. No blistering.
Left arm soreness and pain day after second dose.  Pain was intense shooting down my arm and hand. Could not use my arm for several days.  Could not make a fist. Could mot lay on back or sides to sleep. Had to sit up to sleep for several days. I googled heart attack symptoms since it was my left arm.  I was told to go to ER if it got worse ( nurse at my office ). I could never speak to a human at Hospital.  I spoke with a nurse at today - possibly a nerve was involved ?  My left arm and hand is now numb and tingly.  Just trying to find out if this is a side effect !!!  Symptoms after second shot - left arm and hand pain.  Soreness all over and no energy. Also headache.  Right now the numbness is continuing - going into the third week after the injection.
Injection day: several hours after injection: Pain at injection site radiating up into shoulder Extreme fatigue to the point of not being able to function Headache Took Tylenol 1000 mg went to sleep at 8 pm Day 1 after injection:  Arm sore Woke with headache and nausea Woke to metallic salty taste in mouth/throat (almost like swallowing sea water) Persistent cough (like throat tickle)  Took Tylenol Cold  Fatigued despite sleeping nearly 10 hours night prior All food and drink tastes metallic/salty  Headache continues to worsen Took Aleve/Tylenol combination pill Body aches Day 2 after injection: Woke with headache and nausea Metallic/Salty taste worsened  over night Cough worsened Stiffness/Sore at injection site, neck and shoulder pain spanning across upper back Extreme fatigue Extreme thirst (does not take away metal/saltwater taste in mouth) Will continue to monitor and take over the counter pain relief unless symptoms worsen
died after getting it; This is a spontaneous report from contactable other healthcare professional. A 16-year-old patient of an unspecified gender received BNT162B2 (COMIRNATY), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced died after getting it (the Pfizer vaccine) on an unspecified date. The outcome of the event was fatal. The patient died on an unspecified date.  It was not reported if an autopsy was performed.  The lot number for BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment. However, per company causality assessment guidance, the event of death with unknown cause is assessed as related until the cause of death is clarified.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: died after getting it
After receiving Gardasil vaccine #1 pt immediately became lightheaded, weak and sweaty. SX lasted approx 5 minutes. (OMIC). Per 60 day follow up: Patient received GARDASIL # 2 on 2/20/07, uneventful.
Pt came in for an appointment with PA on 12/2/14. Pt complained of reaction of injection site and warm, pruritic and sore to touch. Pt took BENADRYL and iced it that night. Clinicial confirmed reaction to "pneumococcal immunization." Advised to recheck if worsening.
Neurological effects; This is a spontaneous report from a contactable consumer(patient). A 68-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: El9264) and first dose both via an unspecified route of administration in left arm on 02Feb2021 13:00 at single dose for Covid-19 immunization. Medical history included guillain-barre syndrome. The patient's concomitant medications were not reported. No prior vaccinations within 4 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient not tested with COVID-19 post vaccination. On 05Feb2021 06:00, the patient experienced neurological effects. Adverse event was resulted in [Doctor or other healthcare professional office/clinic visit]. No treatment was received for the adverse events. The outcome of events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 62 year old female who on 29-OCT-2007 was vaccinated SC with a dose of ZOSTAVAX (Oka/Merck).  On 29-OCT-2007 the patient experienced redness "that wrapped around her right arm (injection arm) starting from the shoulder and going down to her fingers.  The patient also experienced neck stiffness, pain in the neck, arm and fingers.  The patient also experienced a rash at the waist line and back.  She was itchy around her back and toward her right side with a slight fever and all around flu-like symptoms.  No medical attention was sought.  The outcome was reported as not recovered.  No further information was provided.  There was no product quality complaint.  Additional information has been requested.
"Moderna COVID-19 Vaccine " approximately 30 hours after vaccine  at injection site on right  arm increased tenderness and very warm -hot at site.  lasted most of the evening 3- hours  with a cold pack applied and NSAID  to reduce  pain.
Patient hospitalized for cesarean delivery within 6 weeks of receiving COVID vaccination. Per doctor's notes: "Pregnancy complicated by fetal pyelectasis on ultrasound.  She progressed to 10cm dilation and had a prolonged second stage of labor with maternal exhaustion.  Minimal descent noted without pop-offs, thus consented for primary cesarean delivery on 6/12.  Fetal macrosomia noted at time of delivery, 4565g. Postoperatively she did well. her Hgb was 10.1. She was ambulating and voiding without difficulty. She was tolerating PO without nausea or vomiting. Pain was well controlled. She was found to be adequate for discharge.
Headaches; body aches;  chills; fatigue;  joint pain, muscle stiffness; extreme left arm pain.  Ongoing itchiness/swelling in the palms and head. This lasted greater than 2 days
Initial report received on 28 September 2011 from a consumer. A female patient (date of birth reported) whose medical history was unknown had received a dose of H1N1 2009 Monovalent Vaccine - Preservative (lot number unknown) on an unknown date and within minutes of receiving the vaccination felt itchy. Her lips then started to swell and she felt like her throat was closing. She was administered epinephrine and monitored. She was subsequently treated with another unknown medication and recovered. The consumer did not have any other information to offer about the reaction since it happened so long ago; and she did not want to be contacted any further; however contact information where the vaccination was administered was provided and follow-up has been requested. Documents held by sender: None.
PATIENT WALKED IN, SPEAKING IN FULL SENTENCES C/O HEADACHE, ABDOMINAL PAIN, BODY ACHES/PAIN IN LEGS THAT BEGAN YESTERDAY AT 2200; TOOK ACETAMINOPHEN.  SHE NOTICED THE HIVES ON HER ARMS AND BACK THIS MORNING ABOUT 0900, BUT DIDN'T SEEK MEDICAL ATTENTION UNTIL NOW @ 1352.  RED HIVES NOTED ON BILAT. ARM, BACK ARE FLESH COLOURED HIVES.  LEFT ARM AT INJECTION SITE RED AND INDURATED; PAINFUL PER PT.  DENIES SOB, DIFFICULTY BREATHING, CHEST PAIN, DIZZINESS OR FAINTING WHEN ASKED.
headache; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills). On 16-Feb-2021, HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills) had resolved.
excess phlem; Exhaustion; Body aches; fever; chills; cold sweat; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=EL3247), via an unspecified route of administration on right arm on 04Feb2021 10:00 (at age of 48 years old) at single dose for COVID-19 immunization. Medical history included spinal stenosis, liver hemangiomas, uterine fibroids, parapelvic and renal cysts, complex left ovarian cysts, PTSD (Post-traumatic stress disorder), pap smear atypical cells of undetermined significance, endometrial cells, bacterial vaginosis, HPV (Human papilloma virus infection), osteopenia, anemia, patellar tendenitis, right hip impingement, left shoulder impingement syndrome, microscopic hematuria, hiatal hernia, cricopharyngeal spasms and allergies to contrast die. Concomitant medication included pregabalin (LYRICA), sertraline hydrochloride (ZOLOFT), colecalciferol (VIT.D3) and glutathione. The patient previously received first dose of BNT162B2 (Lot number=EL3247) on 15Jan2021 at 10:45 AM on right arm for COVID-19 immunization. The patient experienced excess phlem, exhaustion, body aches, fever, chills, cold sweat on 04Feb2021 17:00. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment from events. The outcome of events was recovered in Feb2021.
Patient was inadvertently administered a second dose of high-dose influenza this year. He received the first dose on 9/20/22.
it is not an adverse event, the patient got janssen shot at the pharmacy without telling the pharmacist that he got moderna 6 months ago somewhere else , during the 15 minutes waiting time he tells the pharmacist that his physician advised him to get JJ also to boost his immunity since he has medical issues that effect his immunity. patient was fine when he left
soreness in my arm, bone in my under arm; soreness in my arm, bone in my under arm; right side of my breast is swollen; body ache; Fever; I just don''t feel good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 31Jan2022 (Lot number: FH8027) at the age of 46 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "Polycystic disease" (unspecified if ongoing), notes: Verbatim: polycystic disease; "Hypertension" (unspecified if ongoing), notes: Verbatim: Hypertension; "Blood pressure" (unspecified if ongoing), notes: Verbatim: Blood pressure. Concomitant medication(s) included: NORVASC taken for blood pressure measurement; LOZOL taken for blood pressure measurement; HCTZ taken for blood pressure measurement. Vaccination history included: Covid-19 vaccine (Manufacturer Unknown, Dose number : Unknown), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), BONE PAIN (non-serious) all with onset 2022, outcome "unknown" and all described as "soreness in my arm, bone in my under arm"; BREAST SWELLING (non-serious) with onset 2022, outcome "unknown", described as "right side of my breast is swollen"; PAIN (non-serious) with onset 2022, outcome "unknown", described as "body ache"; PYREXIA (non-serious) with onset 2022, outcome "unknown", described as "Fever"; FEELING ABNORMAL (non-serious) with onset 2022, outcome "unknown", described as "I just don''t feel good". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, bone pain, breast swelling, pain, pyrexia, feeling abnormal.  Additional Information: It was reported that the patient took the Pfizer booster on Monday, was having like soreness in her arm, bone in her under arm, right side of her breast was swollen, she was having body ache, she was having fever,she just didn't feel good. It was further reported that she just had her blood work done. she got the blood work done, everything was fine. They did the PCR testing and it was negative, she was fine beside those things. she had Tylenol, she was taking, every 6 hours. There was no Prior vaccination.    No follow-up attempts are possible. No further information is expected.